Equifax (EFX) stock fell by 2.07% due to its higher volatility compared to the market and potential investor concerns about performance despite having stronger ratings and earnings compared to Pharma-Bio Serv.

Equifax (EFX) stock fell by 2

Equifax (EFX) stock rose 2.6% following the company's quarterly earnings report that exceeded analyst expectations with a reported EPS of $2.00, along with positive revenue growth, indicating strong performance in the credit services sector.

Equifax (EFX) stock rose 2

Equifax (NYSE: EFX) saw a slight increase of 0.11% in stock price, despite a price target decrease by BMO Capital Markets due to better-than-expected quarterly earnings that surpassed analysts' estimates. 

The increase in Equifax's stock can be attributed to positive quarterly earnings, reporting $2.00 per share, which exceeded the consensus estimate of $1.92, and a revenue increase that outperformed expectations.

Equifax (NYSE: EFX) saw a slight increase of 0

Equifax (EFX) stock rose by 0.05%, primarily influenced by the increased holdings of institutional investors, such as the Teachers Retirement System of the State of Kentucky, positive quarterly earnings that exceeded estimates, and favorable ratings from several research analysts.

Equifax (EFX) stock rose by 0

Equifax's (NYSE: EFX) stock rose 0.05% following a quarterly earnings report that exceeded expectations, with earnings per share of $2.00 surpassing the consensus estimate of $1.92 and a revenue increase of 7.4% compared to the previous year.

Equifax's (NYSE: EFX) stock rose 0

Equifax (EFX) stock fell by -8.18%, possibly due to investors reacting negatively to ongoing concerns regarding cybersecurity and data breaches, particularly in light of recent discussions highlighting past incidents like the Equifax data breach itself.

Equifax (EFX) stock fell by -8

The Equifax (EFX) stock price fell by 8.18% due to concerns over rising default rates among consumers amid inflationary pressures, which were highlighted by the recent financial results from Synchrony, indicating a potential deterioration in consumer financial health.

The Equifax (EFX) stock price fell by 8

Equifax (EFX) stock declined by 1.31% as institutional investors, including Stephens Inc., reduced their holdings, and recent insider sales by executives may have raised concerns about the company's potential for future growth.

Equifax (EFX) stock declined by 1

Equifax (EFX) stock rose by 0.64% following positive earnings reports that exceeded analyst expectations, upgrades in target prices by several research analysts, and ongoing interest from institutional investors.

Equifax (EFX) stock rose by 0.64% due to a mix of institutional investors adjusting their holdings, positive earnings results exceeding expectations, and recent upgrades in price targets by several equities research analysts.

Equifax (EFX) stock rose by 0.75% due to a market reaction to Fair Isaac Corporation (FICO) facing increased competition from VantageScore 4.0, which may alleviate regulatory concerns and sustain demand for FICO scores, indirectly benefiting other credit scoring companies like Equifax.

Equifax (NYSE:EFX) stock decreased by 0.27% due to a series of downgrades in target prices and ratings by several research firms, including Barclays and Bank of America, following recent executive stock sales and shifting analyst sentiment.

Equifax (NYSE:EFX) stock decreased by 0

Equifax (EFX) stock experienced a slight decline of 0.27%, continuing a trend as part of the broader telecommunications sector's fluctuating performance, driven by factors such as trading volume fluctuations and market volatility.

Equifax (EFX) stock experienced a slight decline of 0

Equifax (EFX) stock increased by 0.59% likely due to positive expectations ahead of its Q2 2025 earnings report, with analysts projecting earnings growth and a favorable outlook for the fiscal year.

Equifax (EFX) stock increased by 0

Equifax (EFX) stock rose 0.03% likely due to increased competition in credit scoring from the introduction of VantageScore 4.0, which positively impacted credit bureau stocks amid a generally favorable outlook for the sector.

Equifax (EFX) stock rose 0

Equifax (EFX) stock saw a slight increase of 0.03% last night, attributed to institutional investors adjusting their positions, positive quarterly earnings surpassing expectations, and raised price targets from several analysts suggesting a favorable outlook for the company's future performance.

Equifax (EFX) stock saw a slight increase of 0

Equifax (EFX) stock rose by 0.03% following an increase in its price targets from multiple analysts, including Wells Fargo's upgrade from $306 to $310, indicating positive sentiment and expectations for the company's performance.

Equifax (EFX) stock fell by 0.21% amidst a backdrop of increased institutional investments and executive stock sales, which may have contributed to investor concerns about insider selling and its potential impact on market confidence.

Equifax (EFX) stock fell by 0

Equifax (EFX) stock declined by 0.59% after a report highlighted significant insider selling, where both the CEO and an executive vice president sold portions of their shares, which may have raised concerns among investors regarding the company's future prospects.

Equifax (EFX) stock declined by 0

Equifax (EFX) stock rose by 1.76% following a week of positive performance in major stock indexes like the S&P 500 and Nasdaq, which reached record levels despite signs of a slowing economy and consumer discomfort impacting spending and credit behaviors.

Equifax (EFX) stock rose by 1

Equifax (EFX) stock fell by 1.44% after being downgraded from a "buy" to a "neutral" rating by Bank of America, which also reduced its price target for the stock.

Equifax (EFX) stock fell by 1

Equifax (EFX) stock fell 1.44% amid mixed analyst ratings and price target adjustments, which reflected concerns about its valuation despite strong quarterly earnings performance.

Equifax (EFX) stock fell 1

Equifax, Inc. (NYSE: EFX) experienced a 1.44% decline in its stock price following mixed signals from recent institutional investor activities, insider sales, and lowered price targets from several research firms, despite reporting earnings that surpassed analysts' expectations. 

The stock price decline may be attributed to these factors, particularly the sale of shares by executives and adjustments in target prices by analysts.

Equifax, Inc

Equifax (EFX) stock rose 2.64% due to ongoing interest from institutional investors, relatively strong financial performance exceeding earnings expectations, and positive analyst ratings despite some mixed evaluations.

Equifax (EFX) stock rose 2.64% after several hedge funds disclosed significant increases in their stakes in the company and following positive earnings results that exceeded analyst expectations.

Equifax (EFX) stock declined by -0.24% amid overall market unease due to geopolitical tensions in the Middle East and mounting economic indicators pointing to a softening consumer outlook, including declining retail sales and rising delinquencies.

Equifax (EFX) stock declined by -0

Equifax's stock (NYSE: EFX) declined by 0.24% due to recent insider share sales by top executives, including the EVP and CEO, which often raises concerns among investors regarding the company's future performance.

Equifax's stock (NYSE: EFX) declined by 0

Equifax (NYSE: EFX) stock rose by 0.91% due to Stifel Nicolaus raising its target price from $277 to $295, with multiple analysts maintaining buy ratings and positive earnings performance boosting investor confidence.

Equifax (NYSE: EFX) stock rose by 0

Equifax (EFX) stock rose by 0.91% following an "outperform" rating reissued by Royal Bank Of Canada with a target price of $300, indicating a potential upside from its previous close and positive sentiment from multiple equity analysts regarding the company's performance and outlook.

Equifax (EFX) stock was down by 1.02% due to ongoing concerns about medical debt affecting consumers' credit scores, despite reforms that have softened its impact.

Equifax (EFX) stock was down by 1

Equifax (EFX) stock dropped by 1.74% amidst mixed institutional investment activity and recent insider selling by executives, as well as varying analyst ratings and target price adjustments. 

The decline in Equifax's stock can be attributed to potential investor concerns over recent insider sales by executives and mixed analyst reports, which included a downgrade from Barclays, signaling fluctuating confidence among investors.

Equifax (EFX) stock dropped by 1

Equifax's stock (NYSE: EFX) dropped by 0.93% despite receiving a restated "overweight" rating with an increased target price from Morgan Stanley, likely due to overall market movements or profit-taking following recent positive analyst ratings.

Equifax's stock (NYSE: EFX) dropped by 0

Equifax (EFX) stock rose by 1.34% likely due to the impending mortgage renewal challenges facing Canadian homeowners, which may increase demand for credit monitoring and related services as many face rising payments and debt levels.

Equifax (EFX) stock rose 1.45% as it continues to demonstrate strong performance, outpacing the market over the past 15 years with an average annual return of 15.61%, driven by its significant market capitalization of $32.56 billion.

Equifax (EFX) stock rose 1

Equifax Inc. (NYSE: EFX) stock dropped by 6.68% due to recent downgrades and adjustments in price targets by several investment analysts, along with notable insider selling, indicating potential lack of confidence in the stock's future performance.

Equifax Inc

Equifax (EFX) stock declined by 1.25% likely due to recent insider selling by executives and downward revisions of target prices by several research analysts, which may have contributed to investor concerns.

Equifax (EFX) stock fell by 1.25% due to a combination of insider share sales and analysts adjusting their price targets after the company's recent earnings report.

Equifax (NYSE: EFX) saw a 1.28% rise in its stock price likely due to positive earnings results that exceeded market expectations and an increase in its quarterly dividend, which boosted investor confidence.

Equifax (NYSE: EFX) saw a 1

Equifax (EFX) stock decreased by 0.98% following a report that Ameriprise Financial Inc. reduced its holdings in the company by 16.4%, along with sales of shares by executives, indicating potential concerns from institutional investors and insiders about the stock's performance.

Equifax (EFX) stock decreased by 0

Equifax (EFX) stock rose by 1.43% following an increase in FY2025 earnings per share estimates by William Blair analysts, who raised their forecast from $7.45 to $7.57, coupled with a generally positive outlook from multiple research firms.

Equifax (EFX) stock rose by 1.43% following William Blair's upward revision of its Q2 2025 earnings per share estimate from $1.82 to $1.91, indicating favorable performance expectations for the credit services provider.

The article does not directly discuss Equifax (EFX) stock or the reasons behind its recent 0.91% increase; however, Equifax's stock may have risen due to positive market sentiment, improved financial performance, or favorable industry trends that typically influence investor confidence.

The article does not directly discuss Equifax (EFX) stock or the reasons behind its recent 0

Equifax Inc. (NYSE:EFX) experienced a slight decline of 0.06% in its stock price, despite having its Q2 2025 earnings estimates raised by Needham & Company, likely influenced by mixed ratings and target price adjustments from various analysts indicating uncertainty in market sentiment.

Equifax (EFX) stock experienced a slight decline of 0.06%, likely influenced by broader market volatility stemming from concerns about potential tariffs and corporate tax changes, despite the company reporting year-on-year revenue growth and beating analyst expectations.

Equifax Inc. (NYSE:EFX) stock rose by 3.16% after the company reported stronger-than-expected earnings and announced an increased quarterly dividend, which generally boosts investor confidence and interest in the stock.

Equifax (EFX) stock surged 13.8% after the company reported better-than-expected profits for the first quarter of 2025 and announced plans to return more cash to shareholders through increased dividends and a $3 billion stock buyback over four years.

Equifax (EFX) stock surged 13

Equifax (EFX) stock surged 13.84% following the company's strong earnings and revenue results, which surpassed forecasts, as well as the announcement of a new stock buyback program and a dividend increase.

Equifax (EFX) stock surged 14.5% due to better-than-expected first-quarter profits and an announcement of increased shareholder returns through dividends and stock buybacks.

Equifax (EFX) stock surged 14

The Equifax (EFX) stock rose by 0.9% last night due to investor confidence possibly driven by recent company initiatives or positive market trends relevant to its operations in data and credit reporting, which can enhance its financial performance.

EFX

Latest News & Analysis